ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HP
Hôpital Saint-Louis (AP-HP) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hôpital Saint-Louis (AP-HP) takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans treatment and research across breast, bladder, skin, blood and colorectal cancers. It examines whether targeted therapies could replace immunochemotherapy for follicular lymphoma.
| Organization | ESMO 2026 Attendance |
|---|---|
HP Hôpital Saint-Louis (AP-HP) Paris, France | |
Public teaching hospital in Paris, France, part of the AP-HP hospital system and affiliated with Université Paris Cité. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Chair Sat Oct 24 10:15–11:45 Challenging clinical scenarios in melanoma and skin cancers Melanoma & skin cancers Talk Sat Oct 24 10:35–10:55 Immunocompromised patients, including transplant and HIV Melanoma & skin cancers Chair Sun Oct 25 08:30–10:00 Changing paradigms in lymphomas and myeloma Haematological malignancies Talk Sun Oct 25 09:10–09:30 Will targeted therapies replace immuno-chemotherapy in the treatment of follicular lymphoma? Haematological malignancies Abstract Sun Oct 25 11:03–11:13 693O - First-in-humanTERT-targeting nanoaggregate vaccine shows safety and induces intratumoral immune responses in newly diagnosed glioblastoma Sarcoma, CNS, head & neck and rare cancers Poster Sun Oct 25 12:00–12:45 Transcriptomic predictors of early progression and death in metastatic colorectal cancer treated with FOLFIRI-bevacizumab: Pooled analysis of PRODIGE-9 and FIRE-3 Gastrointestinal cancersBiomarkers & precision oncology Talk Tue Oct 27 11:40–12:00 |
Find decision makers at Hôpital Saint-Louis (AP-HP)
Tell us what you sell and we’ll find the people at Hôpital Saint-Louis (AP-HP) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction